# Innovative Approaches for Personalised Cardiovascular Prevention

Study · id `cardio:ct-nct05883878` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05883878](<https://clinicaltrials.gov/study/NCT05883878>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05883878

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1020 participants.

## Technical summary

Registry record NCT05883878. Randomized; no masking; primary purpose prevention. Start 2023-07-24 (actual); primary completion 2025-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1020 participants (planned count; ClinicalTrials.gov record NCT05883878, source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)
- Started: 2023-07-24 (actual) (ClinicalTrials.gov record NCT05883878, source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)
- Primary completion: 2025-11 (anticipated) (ClinicalTrials.gov record NCT05883878, source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)
- Completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT05883878, source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT05883878, source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05883878-2025-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Innovative Approaches for Personalised Cardiovascular Prevention
- Acronym: INNOPREV
- Condition: Cardiovascular Diseases
- Intervention (Genetic): PRS
- Intervention (Device): Digital app and wearable device
- Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Lead sponsor class: OTHER
- Collaborator: University Of Perugia
- Collaborator class: OTHER
- Collaborator: Policlinic Hospital "G. Rodolico"
- Collaborator class: OTHER
- Collaborator: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (`cardio:org-fondazione-policlinico-universitario-agostino-gemelli-irccs`)

## Provenance

Content hash: e3adcd379cfe44cda4e38d02cd0760cacd93f4369060fed51f9503dcb0ea84ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
